Total Pageviews

Friday, April 1, 2022

April 2022 COVID Articles and Videos (Highwire, Truth For Health Vaccine Injury Reporting System, Cancer Trend, Paxlovid Rebound Problem)

 Do Your Own Research - Not medical advice - Make your own decisions - Think for yourself 

 https://stopworldcontrol.com/








April 23, 2022 American Thought Leaders  “Basically they took almost the exact same drug as Kaletra, dressed it up, they put a box around it, and they’re selling it for what, [$]5 billion?” says Urso, referring to the Paxlovid COVID-19 pill.





+++


BOB SNOW - AIRLINE PILOT WHO HAD A HEART ATTACK ON THE FLIGHT DECK SPEAKS OUT ABOUT THE FORCED VAX April 19,2022

+++

REAL NOT RARE

+++

+++

Dr. Ryan Cole: Alarming Cancer Trend Suggests COVID-19 Vaccines Alter Natural Immune Response


“We’re seeing an alteration of the innate immune response,” says pathologist Dr. Ryan Cole, founder of Cole Diagnostics.

In recent months, Cole said he started seeing a number of disturbing trends under the microscope: the appearance of a childhood disease in adults and an uptick in rare cancers. Other doctors have echoed his observations, he says, but rigorous studies are not being conducted.

“You cannot find that for which you do not look,” he says.

We also take a look at what factors impact how an individual fares with COVID-19. America has a vitamin D crisis, which is essential to a functioning immune system, Cole says. “This is a public health message that is so critical, because so goes your vitamin D level, so goes your overall ability to fight off not just COVID, but any virus in any viral season.”

 

Jan Jekielek: Dr. Ryan Cole, such a pleasure to have you on American Thought Leaders.

+++

interview with Jay BhattacharyaBill Whalen
Tuesday, April 19, 2022
Does a Florida judge’s decision to strike down the federal mandate for wearing masks mark a shift from pandemic to endemic thinking? Dr. Jay Bhattacharya, a Hoover senior fellow, a Stanford University professor of medicine, and an epidemiological researcher, discusses the efficacy of mask-wearing, the nuances of the BA.2 variant, lessons from past lockdowns, plus a proposed bill in Sacramento that would suppress COVID dissenters in California’s medical community.

+++


What is Killing Millennials?; Airlines Ready to Drop Masks; Chaos & Hypocrisy in NY; Cleveland Clinic Denies Child’s Kidney Transplant; Huge ICAN-funded Legal Win; Get to L.A. April 10th!  


(3/24/22)
+++

+++

The "Paxlovid Rebound" Problem is Real

Not a "Mystery" or a "Puzzle" and we should have been warned about it.


+++


EPISODE 261: CALIFORNIA SCREAMIN’ (3/31/22)  


California’s 10 Tyrannical Bills; FDA Shows Cards in Booster Approval; Ex-Sky News Exec Blows Whistle on Government Censorship; V is for Vaccine; A Doc Who Wants to Defeat The Mandates

Guests: Amy Bohn, Mark Sharman, Josh Coleman, Jeffrey Barke, MD


+++

Truth for Health Foundation announces new vaccine injury reporting system

Press Conference Wednesday, April 13th 

+++

EPISODE 263: RISKING IT ALL

Thousands Turn Out For Defeat The Mandates; Speaker/Emcee Reflects on Rally; Brutal Lockdowns in China; US Confused Over Covid Policy; The Pandemic of Human Trafficking; Del’s Message for Humanity

+++

FDA Rubber-Stamps Remdesivir for Infants Without Evidence of Safety, Efficacy

The U.S. Food and Drug Administration on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants 4 weeks and older, despite having no evidence the treatment is effective or even safe for young children.


+++

04/27/22

Lawmakers Push FDA on COVID Shots for Infants and Toddlers, Pfizer Asks FDA to Authorize Third Shot for Kids 5 to 11

In a letter to the U.S. Food and Drug Administration, members of the House coronavirus committee asked for a briefing on the status of COVID-19 vaccines for infants and children 6 months to 5 years, claiming “millions of young children still remain unprotected because no vaccine has yet been authorized” for this age group.

+++

The Vaccine Injured and their Fight for Treatment Transparency






No comments:

Post a Comment